These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3697857)
1. Withdrawal of oxyphenbutazone: what about phenylbutazone? Biron P CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857 [No Abstract] [Full Text] [Related]
3. Anti-inflammatory drugs under fire. Loshak D Lancet; 1985 Feb; 1(8425):410. PubMed ID: 2857466 [No Abstract] [Full Text] [Related]
4. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
5. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine). Krook G Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265 [No Abstract] [Full Text] [Related]
6. Phenylbutazone and oxyphenbutazone: time to call a halt. Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755 [No Abstract] [Full Text] [Related]
8. Fixed drug eruption to oxyphenbutazone and phenylbutazone. Nayyar KC; Pasricha JS Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722 [No Abstract] [Full Text] [Related]
9. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
10. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
11. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin). Krook G Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243 [No Abstract] [Full Text] [Related]
12. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone. Pandhi RK; Dedi TR Arch Dermatol; 1975 Jan; 111(1):131. PubMed ID: 1119818 [No Abstract] [Full Text] [Related]
13. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881 [No Abstract] [Full Text] [Related]
14. Phenylbutazone and oxyphenbutazone. Med Lett Drugs Ther; 1973 Apr; 15(9):40. PubMed ID: 4704701 [No Abstract] [Full Text] [Related]
15. [Clofezone and oxyphenbutazone excluded from dental use]. Tamura T Nihon Shika Ishikai Zasshi; 1984; 37(4):391-5. PubMed ID: 6241218 [No Abstract] [Full Text] [Related]
16. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone. Sperling IL Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850 [No Abstract] [Full Text] [Related]
17. [Ketazon not more gentle to the stomach than Blutazolidin]. Kuschinsky G Med Klin; 1972 May; 67(19):686. PubMed ID: 5054952 [No Abstract] [Full Text] [Related]
18. A compliance study in general practice of patients switched from phenylbutazone and oxyphenbutazone to naproxen and other non-steroidal anti-inflammatory drugs. Dickson DJ; English JR Curr Med Res Opin; 1982; 8(1):61-6. PubMed ID: 6980773 [TBL] [Abstract][Full Text] [Related]
19. Drug reaction from oxyphenbutazone. Valsecchi R; Tornaghi A; Falgheri G; Rossi A; Cainelli T Contact Dermatitis; 1983 Sep; 9(5):419. PubMed ID: 6226482 [No Abstract] [Full Text] [Related]
20. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824 [No Abstract] [Full Text] [Related] [Next] [New Search]